Investment Thesis — Houlihan Lokey, Inc.
The market is overly focused on HLI's cyclical exposure to M&A and capital markets, punishing the stock for a temporary downturn. This misprices HLI's robust counter-cyclical restructuring business and its strong competitive position, which is poised to capture significant upside when deal activity inevitably rebounds.
Catalysts
- Clear signs of an M&A market rebound (e.g., increased deal announcements, higher transaction volumes).
- Stronger-than-expected performance from the restructuring advisory segment, demonstrating its counter-cyclical value.
- Positive commentary from management on the deal pipeline and market share gains.
Risk Factors
- A sustained global economic slowdown or recession that further depresses M&A and capital markets activity.
- Intensified competition in advisory services leading to fee compression or loss of market share.
- Unexpected regulatory changes impacting financial services or specific transaction types.
Key Debates
Fwd Rev Growth exceeds 18% by Q4 2024
HLI's Fwd P/E expands to 25x by H1 2025
Restructuring revenue exceeds 25% of total by Q4 2024